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The accessibility of plasma retinol and retinoic acid to
the epidermis may be influenced by the number and
metabolic capacity of fibroblasts in papillary dermis. The
metabolism of retinol-binding protein-bound all-trans-
retinol, and albumin-bound all-trans-retinoic acid, by
fibroblasts cultured on plastic dishes or in type I collagen
gels, was examined. There were no significant differences
in the metabolism of either retinoid by fibroblasts as a
function of culture condition. There were large differ-
ences between retinoids, however. Retinoic acid was
rapidly taken up and metabolized to unidentified polar
metabolites that were released to the medium. Metabolic
capacity was not saturated up to a medium retinoic acid
concentration of 1 mM, and was induced further by prior
Retinoic acid (RA) is an active form of vitamin A,retinol (Roh), that is essential for normal epithelialhomeostasis (Gudas et al, 1994). This signaling molec-ule influences the transcription of retinoid-responsivegenes in target cells by its reversible binding to nuclear
retinoid receptors (reviewed by Gudas et al, 1994; Mangelsdorf et al,
1994). Two sources of RA are potentially available to epithelial tissues.
First, RA can be generated in the skin following the uptake and local
metabolism of plasma Roh that is transported bound to retinol-binding
protein (Blaner and Olson, 1994). Second, in addition to Roh, RA is
also present in the circulation bound to albumin (Lehman et al, 1972;
Smith et al, 1973; for review, see Blaner and Olson, 1994) and is taken
up by a variety of cell types, contributing significantly to tissue RA
pools in some cases (Kurlandsky et al, 1995). Both Roh and RA are
present in the plasma under normal physiologic circumstances, although
at different concentrations. Retinol is present in human plasma bound
to retinol-binding protein (RBP) at 1–2 µM (Blaner and Olson, 1994;
Soprano and Blaner, 1994) and RA is present in human plasma at
4–14 nM (De LeenHeer et al, 1982; Eckhoff and Nau, 1990).
The differentiation program of epidermal keratinocytes is sensitive
to exogenous retinoid, including Roh and RA (for reviews see
Vahlquist and To¨rma¨, 1988; Fuchs, 1990; Darmon, 1991). Normal
differentiation is altered by excess or deficiency of either of these
retinoids. For example, Asselineau et al (1989) have demonstrated that
keratinocytes maintained on dermal equivalent cultures at the air–
liquid interface exhibit a normal pattern of differentiation only when
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exposure to retinoic acid. In contrast, retinol, although
readily taken up, was not metabolized, i.e., neither
retinoic acid nor retinyl ester was formed. By immuno-
histochemistry, the average number of fibroblasts in a
100 mm thickness of papillary dermis was estimated to
be 1 H 106 cells per cm2. Utilizing this value, the
capacity of dermal fibroblasts to metabolize retinoic
acid based on fibroblast abundance in the dermis was
calculated. The results suggest that fibroblasts could
limit delivery of plasma retinoic acid but not retinol
to the epidermis on the basis of their metabolic capacity
and abundance in the dermis. Key words: epidermis/high
performance liquid chromatography/retinol-binding protein/
skin/vitamin A. J Invest Dermatol 111:478–484, 1998
medium contained a suitably low concentration of serum. Two
conclusions follow these and other similar observations. One, exogenous
retinoid is essential for normal keratinocyte differentiation. Two, normal
differentiation is observed when extracellular retinoid concentration falls
within a critical range; concentrations either above or below this do
not support normal differentiation.
The concentration of RA in intact, normal epidermis has been
reported to be 20 nM or lower (Vahlquist, 1982; Kang et al, 1995;
Duell et al, 1996), similar to that found in the plasma (De LeenHeer
et al, 1982; Eckhoff and Nau, 1990). Despite the fact that this
endogenous RA concentration must fall within the critical range
required for sustaining epithelial homeostasis, neither its source(s) nor
the mechanisms by which its levels are controlled are fully understood.
At least some RA in the epidermis may arise via synthesis from
Roh. Cultured epidermal keratinocytes synthesize RA (Randolph and
Simon, 1993, 1996; Kurlandsky et al, 1994), and although RA synthesis
appears to be negatively feedback regulated, RA production persists
despite the availability of exogenous RA (Randolph and Simon, 1996).
This suggests that at least some RA synthesis in keratinocytes is
constitutive. RA synthesis in keratinocytes appears to be controlled, at
least in part, at the level of substrate Roh availability. This involves
RA-mediated regulation of the Roh esterification reaction. Under
RA-sufficient conditions, Roh is esterified, sequestering it from the
enzymes of RA synthesis (Kurlandsky et al, 1996; Randolph and
Simon, 1996). Excessive accumulation of RA is prevented not only
by regulation of synthesis, but also by high capacity metabolism of RA
in keratinocytes (Randolph and Simon, 1997). Thus, maintenance of
an appropriate RA concentration in keratinocytes probably involves
multiple homeostatic mechanisms operating in concert.
In addition to its synthesis in situ from Roh, RA may be available
to the epidermis from the blood supply of underlying dermis. This
possibility is an important consideration because the concentration of
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RA in the plasma and in the epidermis compare so closely, both at or
below 20 nM. Moreover, cells in the dermis could alter plasma retinoids
both qualitatively and quantitatively. The metabolism of RBP-bound
Roh or albumin-bound RA by human fibroblasts, a major cell type
of the dermis, has not been previously studied, and this work was
undertaken to characterize the metabolism of RA and Roh by dermal
fibroblasts under physiologic conditions inasmuch as possible in vitro.
Metabolism studies were conducted on cells grown on plastic tissue
culture dishes and within type I collagen gels in order to assess the
impact of a dermis-like extracellular matrix.
The capacity of dermal fibroblasts to limit the availability of plasma
retinoids to the epidermis is also dependent on the abundance of
fibroblasts in papillary dermis. To assess this, the density of fibroblasts
in human papillary dermis was estimated using immunohistochemistry.
MATERIALS AND METHODS
[11,12–3H(N)]-all-trans-RA, and [11,12–3H(N)]-all-trans-retinol, 50 Ci per
mmol, was purchased from New England Nuclear (Boston, MA). All-trans-
RA, all-trans-retinol, and fatty acid-free bovine serum albumin (BSA) were
purchased from Sigma (St. Louis, MO). Ketoconazole was obtained from
Research Diagnostics (Flanders, NJ). The authentic retinoid standards, 3,4-
didehydro-all-trans-RA and 4-oxo-all-trans-RA, were the generous gift of
Hoffmann-La Roche (Nutley, NJ).
Experimental protocol The overall experimental protocol for labeling and
analyzing cell-associated retinoids has been described in detail previously
(Randolph and Simon, 1993). Brief descriptions of the individual experimental
elements are described below.
Cell culture Human dermal fibroblast strains were obtained from biopsies of
three healthy adults. Stock cultures of cells were maintained in medium
consisting of Dulbecco’s minimum essential medium (Gibco BRL, Grand Island,
NY), containing penicillin (1000 units per ml), streptomycin (1000 µg per ml),
and 10% fetal bovine serum (Hyclone, Logan, UT). Stock cultures were plated
at a density of 3.5 3 103 cells per mm2 and were passaged at µ75%–100%
confluence, which was achieved within 5–7 d. For experiments, fibroblasts of
the same strain and passage and from the same stock culture were grown in
either 100 mm Falcon plastic dishes (Becton Dickinson Laboratories, Lincoln
Park, NJ), or 25 mm Nunc tissue culture inserts (Marsh Biomedical Products,
Rochester, NY), containing type I rat tail collagen (Upstate Biotechnology,
Lake Placid, NY) suspended in 35 mm Falcon plastic plates. Cells were plated
on plastic dishes as described above for stock cultures. Cells in collagen gels
(2 3 105–1 3 106 cells per raft; 3 ml per gel) were suspended in the growth
medium described above and also containing 2 mg type I rat tail collagen per
ml and 1.6 3 10–3 N NaOH. Cultures of cells in the collagen gels and dishes
were fed with 5 ml of the medium described above every other day. For the
collagen gel cultures this volume of medium was distributed both above and
below the gel such that the gel was completely and continuously submerged.
Fibroblasts for experiments were of passage six or less and were allowed to
grow 7 or 8 d following plating (confluence for dish cultures) prior to initiation
of experiments. During this growth interval, the collagen gels spontaneously
contracted and detached from the tissue culture insert walls. The extent of
contraction was generally 25%–50%. On the day of experiments, collagen gels
were removed from the parent wells and transferred to new wells in order to
eliminate cells that had migrated out of the collagen and had become attached
to the plastic insert.
At the end of the experiments, medium was removed and was analyzed as
previously described (Randolph and Simon, 1993). Fibroblasts in dishes were
washed three times with phosphate-buffered saline and harvested by treatment
with 0.025% trypsin. The resulting cell suspension was washed again in
phosphate-buffered saline prior to analysis. Collagen gels were likewise washed
three times with phosphate-buffered saline and were incubated with gentle
agitation at 37°C for µ30 min in a solution of collagenase (Boehringer,
Indianapolis, IN) at a concentration of 3 mg per ml. The collagenase buffer
consisted of 0.13 M NaCl, 0.01 M calcium acetate, and 0.02 M HEPES,
pH 7.2. This treatment resulted in complete digestion of the collagen raft. The
fibroblasts were then recovered by centrifugation followed by a phosphate-
buffered saline wash as described above for dish cultures. The incubations with
either trypsin or collagenase for dish or gel cultures, respectively, were of
equal duration.
[3H]Retinoid substrates All retinoids were stored in the dark under an
atmosphere of N2 at –20°C and when out of storage were kept on ice under
amber fluorescent lighting (GE F40 Gold). [3H]RA- or [3H]Roh-containing
experimental medium was prepared on the day of experiments. Both unlabeled
and radiolabeled RA were purified by normal phase high performance liquid
chromatography (HPLC; described below). Unlabeled and radiolabeled Roh
were purified by reverse phase HPLC (described below).
On the day of the experiments, freshly purified [3H]RA was dried under a
stream of nitrogen and was then dissolved in 40 µl dimethylsulfoxide and added
to a sterile 100 mg per ml solution of fatty acid-free BSA. The [3H]RA-
albumin preparation was added to basal medium containing 10% fetal bovine
serum such that the final added albumin concentration was 1 mg per ml.
Together the added BSA and the native albumin present in 10% fetal bovine
serum yielded a final medium albumin concentration of µ75 µM. This albumin
concentration compares to an albumin concentration in dermal interstitial fluid
of 300 µM (Rossing and Worm, 1981). The binding and stability of [3H]RA
in the BSA preparations and in experimental medium was evaluated as described
previously (Randolph and Simon, 1997). Except as indicated, experiments were
performed with a [3H]RA concentration of µ5 nM. In these studies, the
albumin to RA mole ratio was µ60,000, which compares with an albumin to
RA mole ratio range of 43,000–150,000 in human plasma, based on a plasma
RA concentration range of 4–14 nM (De LeenHeer et al, 1982; Eckhoff and
Nau, 1990) and a plasma albumin concentration of 600 µM (Rossing and
Worm, 1991). Ketoconazole was added to cultures dissolved in a dimethylsulfox-
ide vehicle. A 10 mM stock solution was added to cultures at a volume:volume
ratio of 1000 to yield a final ketoconazole concentration of 10 µM.
Retinol-binding protein-[3H]Roh complexes were prepared as described
previously (Randolph and Ross, 1991), except that RBP was purified from
fresh human plasma as described by Berni et al (1985).
Following preparation, the BSA-[3H]RA, or the RBP-[3H]Roh preparations
were added to medium. For incubations with [3H]RA, the medium consisted
of the growth medium described above. For incubations with RBP-[3H]Roh,
medium consisted of the same growth medium, lacking serum, and containing
20 mg BSA per ml. All experimental medium was prepared on the day
experiments were initiated. Experiments were initiated by the addition of
medium containing radioisotopic-retinoid to cultures.
Retinoid analysis Following experimental incubations with [3H]RA or
RBP-[3H]Roh, fibroblasts and medium were harvested separately, [3H]retinoids
were extracted and analyzed by HPLC. To 1 ml aliquots of a sonicated cell
suspension or medium were added 50 pmol each of the following internal
standards: 4-oxo-RA, 3,4-didehydroretinoic acid, and RA. Total [3H]retinoids
were extracted by the method described by Barua (1991). The organic solvents
for this extraction all contained butylated hydroxytoluene (0.05%). The recovery
of 3H and internal standards by this extraction method was consistently greater
than 96%. Extracts were dried under N2 and dissolved in 100 µl of mobile
phase, all of which was injected for HPLC analysis.
Two separate HPLC protocols were utilized during these studies. The first
employed a reverse phase (Waters 3.9 mm 3 300 mm C18 NovaPak analytical
column) gradient system and was utilized for quantitation of the polar RA
metabolites (Randolph and Simon, 1996, 1997). The second HPLC protocol,
a normal phase system, was employed for the purification of all-trans-RA
(Randolph and Simon, 1996). It consisted of a Waters NovaPak 3.9 3 150 mm
silica analytical column and an isocratic mobile phase consisting of hexanes,
dichloromethane, and glacial acetic acid (170:30:0.1; vol:vol:vol) with a flow
rate of 1.5 ml per min.
The identity of all-trans-RA was checked by chromatography of the methyl-
ated derivative (Randolph and Simon, 1993) by reverse phase HPLC as
described above.
Column effluent was monitored for 3H by scintillation counting of 0.25 min
fractions. Fractions for scintillation counting were collected directly into 7 ml
scintillation vials, mixed with 3 ml Scintiverse BD (Fisher) and counted in an
LKB Rackbeta scintillation counter. The efficiency of counting in this system
was 35%.
Individual [3H]labeled retinoids were identified by matching retention times
of isotope peaks with those of the added internal standards. The individual
[3H]retinoids were quantitated by summing the background-corrected cpm in
each peak. In some cases, background-corrected cpm were converted to pmol
based on the specific activity of the original substrate [3H]retinoid. Typical
background radioactivity ranged between 25 and 40 cpm per fraction. Cell
protein was determined by the method described by Markwell et al (1978).
Measurement of replicating cells Cells in S phase of the cell cycle were
quantitated by staining cell suspensions of harvested cells with a bromodeoxyurid-
ine (BrdU; Boehringer) kit. Prior to harvest, 8 d dish or gel cultures were
incubated with growth medium containing 10 µM BrdU for 1 h at 37°C.
Cultures were harvested as described above and cell suspensions were applied
to slides for BrdU immunostaining. After BrdU staining, cell nuclei were
counterstained with hematoxylin. A total of 500 nuclei were counted and the
fraction of BrdU-stained nuclei was calculated.
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Immunohistochemistry Human skin biopsies (breast skin from breast reduc-
tion surgery) were frozen at –20°C and were cryosectioned tangentially from
the epidermal surface to a depth of µ200 µm. Serial 5 µm tissue sections were
fixed in acetone for 20 min at –20°C. Sections were then incubated with 10 µg
per ml of a monoclonal antibody directed against fibroblast antigen (Ab-1;
Oncogene Research, Cambridge, MA) for 1 h at 37°C in a buffer consisting
of 0.05 M Tris, 0.9% NaCl, pH 7.4. This antibody has been previously
characterized as specific for human dermal fibroblasts (Saalbach et al, 1996).
The primary antibody was localized with Cy3-conjugated goat anti-mouse IgG
(Jackson Immunoresearch, West Grove, PA) at a concentration of 10 µg per
ml under the same conditions listed above for the primary antibody. Cell nuclei
were stained with DAPI-containing Vectashield mounting medium (Vector
Laboratories, Burlingame, CA). Fibroblasts were counted in double exposure
photographs where the Cy3 fibroblast and the DAPI nuclear stains colocalized.
Using these criteria, the number of fibroblasts per cm2 skin surface area was
determined in a total of 100 µm of papillary dermis. Sections from three normal
adult donors were counted.
RESULTS
The objective of the first series of experiments was to determine the
capacity of dermal fibroblasts to metabolize exogenous RA. For this,
the metabolites of fibroblasts grown on plastic or within type I collagen
gels were examined by reverse-phase HPLC. Typical results are shown
in the chromatograms depicted in Fig 1. As a control, experimental
medium containing 5 nM [3H]all-trans-RA was incubated under
conditions identical to those for the cell incubations. This control
medium was extracted and analyzed (Fig 1a) to assess any decomposition
of the RA substrate due to intrinsic instability or incubation conditions.
Under these conditions the RA did not undergo appreciable decomposi-
tion. Normal phase HPLC analysis of the peak of tritiated-RA that is
retained at µ14.5 min revealed a mixture of µ85% all-trans-RA, 15%
13-cis-RA, and a trace of 9-cis-RA (data not shown). These isomers
of RA spontaneously formed upon addition of the all-trans-RA to
the medium (this reverse-phase HPLC system does not resolve the
stereoisomers of RA). The spontaneous isomerization of all-trans-RA
attending its addition to cell culture medium has been observed
previously (Randolph and Simon, 1997).
When extracts of fibroblasts were analyzed by reverse phase HPLC,
only RA was evident (Fig 1b). The quantity of RA in fibroblasts
grown on plastic was approximately 2-fold greater than that in the
fibroblasts in collagen gels. The apparent 4-fold difference seen in
Fig 1(b) is due to a 2-fold difference in cell protein between the two
cultures (see figure legend). Analysis of this RA peak by normal phase
HPLC (data not shown) revealed the same mixture of all-trans- and
13-cis-isomers as that found in control medium mentioned above.
Analysis of medium from the fibroblast cultures demonstrated a peak
of radioactivity eluting in the unretained volume of the column (Vo),
as well as a peak corresponding to the parent RA (Fig 1c). The polar
metabolites eluting in the unretained volume of the column were not
analyzed further. In the dish cultures approximately 2-fold more of the
parent RA had undergone metabolism to the polar material that was
unretained in this chromatography system. This does not represent a
significant difference in metabolism between the two culture systems
but rather reflects differences in cell protein (see figure legend).
In no instance were carbon-4 oxidized metabolites of RA observed.
To control for recovery and detection of this retinoid metabolite,
authentic 4-oxo-RA was added to the analyses as an internal standard
and was recovered with high efficiency. In this HPLC system it
exhibited a retention time of 5.5 min. Importantly, 3,4-didehydro-
retinoic acid was not detected in fibroblast cultures (retention time of
13.5 min). This is noteworthy because 3,4-didehydroretinoic acid is a
metabolite of RA in cultured keratinocytes (Randolph and Simon,
1997).
The time course for uptake and metabolism of RA by cultured
fibroblasts was examined (Fig 2). Fibroblasts rapidly took up medium
RA; cellular concentrations increased µ10-fold over that in medium
by 3 h (Fig 2a) and decreased steadily with further incubation.
Concomitant with rapid RA uptake by cells was the disappearance of
medium RA and the appearance of polar metabolites in cells (Fig 2a)
and the medium (Fig 2b). By 6 h, 60% of medium RA had been
metabolized. Metabolism of RA continued beyond 6 h but was much
Figure 1. Fibroblasts grown on plastic or within collagen gels take up
and metabolize exogenous RA similarly. Seven day old cultures of
fibroblasts grown in plastic dishes or in collagen gels were incubated with
medium containing 5 nM [3H]RA for 24 h. Medium and cells were harvested
separately and analyzed by reverse phase HPLC as described in Materials and
Methods. The chromatogram in (a) represents the [3H]RA recovered from
control medium incubated for 24 h in the absence of cells. The chromatograms
in (b) depict the radioactivity recovered from fibroblasts in collagen gel (open
symbols) and dish (closed symbols) cultures. The chromatograms in (c) depict the
radioactivity recovered from medium of the same fibroblasts cultures in collagen
gels (open symbols) and dishes (closed symbols). Each chromatogram depicts typical
results from all experiments and represents the average of three separate
injections from triplicate incubations of dishes or gels. The retention time for
authentic RA is 14.5 min. The unretained volume of the column (Vo) is
indicated at 2.5 min. Approximately 1 mg of cell protein was analyzed from
the dish cultures and µ0.5 mg of cell protein was analyzed in the collagen
gel cultures.
slower than that observed in the first 6 h of incubation. This was likely
due to decreasing medium and cellular RA concentrations.
The uptake and metabolism of RA by fibroblasts were also deter-
mined as a function of medium RA concentration (Fig 3). The cellular
concentration of RA increased linearly when medium RA was varied
between 1 nM and 1 µM (Fig 3a). Across the entire concentration
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Figure 2. Exogenous RA is rapidly taken up and metabolized by
cultured fibroblasts. Fibroblasts grown on plastic dishes were incubated with
medium containing 0.7 nM [3H]RA for the indicated times. Cells and medium
were harvested separately and analyzed by HPLC. The concentrations of RA
(closed circles) and its polar metabolites (radiolabeled retinoids eluting at Vo, open
triangles) in cells (a) and medium (b) are shown. Values are the average of
triplicate determinations from one experiment that was repeated with similar
results. Error bars: 6SD.
range, cellular concentrations of RA were 2-fold higher in fibroblasts
grown on plastic as compared with those grown within collagen gels.
Despite the difference in cellular RA concentrations between the
two cultures, the rate of RA metabolism was approximately the same
in the physiologic range (up to medium RA concentrations of 10 nM;
Fig 3b). Above this concentration RA metabolism occurred at a faster
rate in fibroblasts cultured on plastic. Metabolism of RA was not
saturable in either culture condition over this concentration range.
The metabolism of 5 nM [3H]RA by fibroblasts grown on plastic and
in collagen gels previously exposed to a pharmacologic concentration of
RA was examined. Fibroblasts in both culture conditions increased
the rate of RA metabolism by µ50% as a result of pretreatment with
1 µM RA (data not shown).
The two culture systems were next compared for their sensitivity to
ketoconazole, an inhibitor of cytochrome P450-linked RA metabolism.
Incubation of cells in both culture systems with 10 µM ketoconazole
inhibited RA metabolism by 50%–75% (data not shown).
By day 8 of culture, when experiments were performed, the cell
protein recovered from the raft cultures was approximately half that
recovered from the dish cultures (0.5 mg protein per gel versus 1 mg
protein per dish). This suggested that fibroblasts cultured in collagen
gels grew more slowly than fibroblasts cultured on plastic. This was
an encouraging observation because a very low proportion of dermal
fibroblasts in vivo are replicating (Kaye et al, 1971; Sarber et al, 1981;
Van Neste and Lachapelle, 1981). To discern if the very high rate of
RA metabolism was related to the percentage of dividing cells, BrdU
incorporation was determined. On day 8 of culture, the percentage of
BrdU positive cells in gels was 1%, and on plastic it was 12%.
In addition to albumin-bound RA, the circulatory system of the
Figure 3. The uptake and metabolism of exogenous RA by cultured
fibroblasts is not saturable at concentrations up to 1 mM. Fibroblasts
cultured on plastic dishes (closed symbols) or collagen gels (open symbols) were
incubated with medium containing the indicated concentrations of [3H]RA for
24 h. Cells and medium were harvested separately and analyzed by HPLC. The
molar concentration of RA in cells at 24 h is shown in (a). Data have been
transformed by the log function. The total mole of polar metabolites produced
per mg cell protein is shown in (b). Data have been transformed by the log
function. The molar concentration of [3H]RA in the original medium, shown
on the x axis, has been log transformed. Values are the average of triplicate
determinations from one experiment that was repeated with similar results.
Error bars: 6SD.
skin delivers RBP-Roh to fibroblasts of papillary dermis. Toward
assessing the metabolic fate of this abundant retinoid substrate in the
dermis, medium containing 1 µM RBP-bound [3H]Roh was incubated
with fibroblasts cultured within collagen gels or in plastic dishes for
24 h (isotopic steady state), and the tritium-labeled retinoid metabolites
were extracted and analyzed by HPLC (Fig 4). The two radiochromato-
grams in Fig 4(a) are representative of extracts of fibroblasts in the
two culture systems. Retinol was taken up similarly by cells in both
culture systems and was present at an intracellular concentration of
µ2 µM. Strikingly, and despite the micromolar intracellular concentra-
tion, there were no metabolites of Roh detected within cells cultured
in either condition, including RA (retention time of 15 min) or retinyl
esters (retention times of 25–35 min) that could be attributed to
metabolic activity of the cells. The trace amounts (,50 nM) of polar
metabolites (Vo) and RA that were detected (not evident in the
chromatogram due to scale of y axis), were present at similar concentra-
tions in control medium incubated in the absence of cells (data not
shown). Analysis of medium from the same cultures (Fig 4b) likewise
resulted in the recovery of essentially only the parent Roh.
Consistent with these radiolabeled studies in other experiments, the
endogenous retinoids present in mass cultured fibroblasts (cells from
ten 180 cm2 flasks) grown in medium containing 10% fetal bovine
serum (µ50 nM RBP-Roh) were analyzed. In these experiments, by
optical detection (photodiode array detection), the only retinoid
detected was Roh (data not shown).
In order to quantitatively predict the metabolic potential of fibroblasts
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Figure 4. Cultured fibroblasts do not metabolize RBP-Roh. Fibroblasts
cultured on plastic dishes (closed symbols) or within collagen gels (open symbols)
were incubated with medium containing the 1 µM RBP-[3H]Roh for 24 h
(isotopic steady state). Cells (a) and medium (b) were harvested separately and
analyzed by HPLC. Approximately 2 mg cell protein were analyzed in each
culture condition. Radiochromatograms represent the average of triplicate
samples. The experiment was repeated with similar results.
in vivo, it was necessary to determine the abundance of fibroblasts
in papillary dermis. To accomplish this, fibroblasts were identified
immunohistochemically in serial, tangential sections of papillary dermis
(Fig 5) using an excellent monoclonal antibody specific for human
dermal fibroblasts (Saalbach et al, 1996). The photomicrograph in
Fig 5(a) is a low power view of a typical section and serves to illustrate
the overall tissue distribution of fibroblasts when viewed tangentially
to the skin surface. Fibroblasts in papillary dermis and in individual
dermal papillae were very close to the epidermis, in many instances
less than 5–10 µm away. Moreover, dense clusters of fibroblasts
completely covered the extravascular side of capillaries. Also noteworthy
were the striking long, thin, spindle-shaped processes of papillary
fibroblasts (note the dashed box in Fig 5a) that are not so evident in
traditional cross-sections. The photomicrograph in Fig 5(b) shows an
enlargement of the cells in the dashed box from Fig 5(a). The slender
fibroblast processes were up to 100 µm in length, and tortuous, and
formed a sieve-like network that completely filled the papillary dermis.
The number of fibroblasts per unit volume of papillary dermis was
determined by counting fibroblasts in photomicrographs where the
fibroblast-specific (red) and the nuclear (blue) stains localized to the
same cell. In the immediate vicinity of blood vessels and hair follicles,
the density of fibroblasts was so high that it was impossible to discern
individual cells. In such cases we did not attempt to score cells. The
data on fibroblast numbers thus represent a lower limit of dermal
fibroblast density. Fibroblasts were counted in photomicrographs from
sections representing a total of 100 µm thickness of papillary dermis.
A typical photomicrograph that was scored for fibroblast numbers is
shown in Fig 5(c). Sections from biopsies of three normal individuals
were scored. The average fibroblast abundance in papillary dermis
from these biopsies was 1 3 106 cells per cm2 skin surface area in
100 µm of dermal tissue (SD; 0.28 3 106 per cm2).
DISCUSSION
These studies have examined the uptake and metabolism of RA and
Roh delivered in physiologic form and concentration by fibroblasts.
Under these conditions, fibroblasts actively metabolize RA but not
Roh. In a recent publication by Bailly et al (1998), the metabolism of
pharmacologic RA and Roh by human dermal fibroblasts was reported.
In their studies, micromolar RA or Roh was delivered to cultured
human dermal fibroblasts in dispersed form, dissolved in ethanol. Under
these conditions, fibroblasts exhibit a robust metabolism of RA to
polar metabolites, similar to the present results. In contrast to the
present studies, however, cultured human fibroblasts appear to convert
solvent-dispersed Roh into trace amounts of RA and modest quantities
of Roh ester (Bailly et al, 1998). The administration of Roh to cells
in this manner delivers up to 10-fold more Roh to cells as compared
with that which occurs when Roh is delivered in physiologic bound
form, bound to RBP (Hodam et al, 1991). It seems likely that these
differences are due to the availability of a very high substrate Roh
concentration to low affinity pathways of metabolism that might be
operative only under pharmacologic conditions. In addition, caution
must be taken in interpreting the presence of RA in cells or medium
when Roh is added to cells in solvent-dispersed form. This manner of
adding Roh to tissue culture medium can result in some spontaneous
oxidation of Roh into RA and other polar metabolites (Randolph and
Simon, 1993).
Cultured fibroblasts exhibit a high capacity to metabolize RA
presented in physiologic form bound to albumin. Does the metabolic
capacity of fibroblasts have potential to play a quantitatively significant
role in limiting the availability of plasma RA to the skin?
The quantitative significance of RA metabolism in fibroblasts can
be gauged by evaluating their metabolic capacity in the context of
extracellular RA concentrations likely to be encountered in vivo.
Although the concentration of RA in human dermis is not known, it
is possible to predict the highest concentration to which dermal
fibroblasts might be exposed. The concentration of albumin in skin
blister fluid has been reported to be around 300 µM, approximately
half its concentration in plasma (Rossing and Worm, 1981). If plasma
albumin permeating into the dermal interstitium retains its function as
the physiologic transport protein for RA in the plasma (Lehman et al,
1972; Smith et al, 1973), the concentration of RA in the dermis
(derived from plasma) should be about one-half of its concentration
in plasma (De LeenHeer et al, 1982; Eckhoff and Nau, 1990), or
µ5 nM. This represents a conservative estimate of RA concentration
because it assumes that there is no metabolism or synthesis by other
cell types. Dermal fibroblasts clearly possess ample biochemical capacity
to metabolize exogenous RA at this concentration (Fig 3). In fact,
RA metabolism in fibroblasts is not saturated at RA concentrations
100-fold higher than those expected in vivo. Thus, if fibroblasts express
a similarly robust capacity for RA metabolism in vivo, metabolism
would be limited by factors other than biochemical potential.
The dermis is rich in extracellular matrix and, from a histologic
point of view, is less cellular than the overlying epidermis. Is RA
metabolism by fibroblasts quantitatively significant on the basis of
cellular abundance?
The number of fibroblasts per unit volume of a 100 µm thickness
of papillary dermis has been estimated to be 1 3 106 fibroblasts per
cm2 skin surface area. Assuming an extracellular RA concentration of
5 nM (see above), fibroblasts metabolize 5 pmol RA per 106 cells per
day (Fig 3). Multiplying this value times the number of fibroblasts per
unit volume of dermis, 1 3 106 cells per cm2, gives a tissue fibroblast
metabolic capacity of 5 pmol RA per cm2 per day, assuming a constant
extracellular RA concentration of 5 nM.
The importance of this metabolic potential must be evaluated in the
context of the exogenous RA supply. The extracellular supply of RA
depends on the RA concentration of interstitial fluid and its rate of
flow through the dermis, a value that can be estimated. The RA
concentration in dermal interstitial fluid is estimated to be µ5 nM (see
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Figure 5. Immunohistochemistry of fibroblasts in tangential sections of human dermis. A biopsy of human skin was frozen at –20°C and 5 µm tangential
sections of papillary dermis were prepared and stained as described in Materials and Methods for a fibroblast-specific antigen. Red staining depicts localization of the
fibroblast-specific antibody. All cell nuclei are stained blue. (a) A low power view (103) of a typical section through the papillary dermis. The ‘‘band’’ of blue
nuclear staining (basal keratinocyte nuclei) across the top of the photograph depicts where the section skimmed the overlying epidermis (above the plane of the
photograph). Individual dermal papillae can be seen as the ‘‘holes’’ in the band of blue nuclei. Note the red staining within the core of each papillae. The dashed
inset depicts the region of this field that was photographed at high power (403), shown in (b). (b) A high power view (403) of fibroblasts exhibiting typical
morphology for papillary dermis. (c) A typical photomicrograph (203) that was used to score the numbers of fibroblasts in dermis. Fibroblasts were counted in
photomicrographs using the criteria of colocalization of nuclear (blue) and fibroblast (red) staining. Some examples of this colocalization are indicated with the
white arrows. Scale bars: 100 µm.
above). Because the concentration of albumin in skin blister fluid
(Rossing and Worm, 1981), interstitial fluid, and lymph (Reed et al,
1993) are similar, the flux of plasma RA (albumin-bound RA) through
dermal interstitium is assumed to approximate the lymph flow from
the skin (Reed et al, 1993). The lymph flow from the skin is
proportional to the proportion of cardiac output to the skin, µ5%
(Tan and Stafford, 1987). Total lymph flow in an adult is µ5 liters per
day (Berne and Levy, 1997). Adult body surface area is assumed to be
2 m2. The estimated supply of RA (originating from the plasma) to
dermis in 1 cm2 of skin is as follows: 5 liters lymph per day 3 0.05 3
5 nM RA/liter 4 20,000 cm2 5 0.06 pmol RA per cm2 per day.
This calculated supply of plasma RA to the dermis is strikingly less
than the metabolic capacity of fibroblasts in a 100 µm thickness of
dermal tissue (5 pM per cm2 per day). Thus, the capacity of RA
metabolism in dermal fibroblasts exceeds the predicted extracellular
supply of RA from plasma both on a biochemical and on a cellular level.
Is RA metabolism in the dermis or epidermis quantitatively important
in maintaining low concentrations of RA in the epidermis? Insight to
this question can be gained by comparing the RA content of the
epidermis with the estimated supply of RA from the microvasculature
of underlying dermis. In the discussion above, assuming no additional
input from synthesis (Fig 4), and no output via metabolism, the
estimated supply of plasma RA to the epidermis is 0.06 pmol RA per
cm2 of skin surface area per day. If this quantity of RA was retained
in a 100 µm thickness of epidermis of the same surface area, its
concentration would increase by 6 pmol per cm3 (6 nM) per day. This
increment is in the range of the RA concentration of epidermis
(,20 nM; Kang et al, 1995; Duell et al, 1996). Under the limitations
of these assumptions, substantial RA metabolism must occur in the
vicinity of the dermal–epidermal interface. These data suggest that this
could occur, at least in part, in fibroblasts of papillary dermis.
Recent results from this laboratory have demonstrated that cultured
keratinocytes also exhibit high capacity to metabolize exogenous RA
(Randolph and Simon, 1997). Cultured keratinocytes resemble the
keratinocytes that are present in wound healing epithelium (Mansbridge
and Knapp, 1987). Replicating keratinocytes are located in the basal
layer of the epidermis, immediately above the papillary dermis and
beneath the differentiating suprabasal cells. Fibroblasts of the papillary
dermis are distributed around the vascular supply of the dermis and
immediately beneath the epidermis. These two cell populations are in
close proximity to each other and could function together as a metabolic
barrier, limiting the access of extracellular RA to differentiating
suprabasal cells of the epidermis.
Epidermal cells are known to require low concentrations of active
retinoid to maintain normal differentiation (Asselineau et al, 1989). If
plasma RA from the dermis has limited availability to the differentiating
epidermal cells due to metabolism at the dermal–epidermal interface,
other sources of RA must be considered for sustaining epidermal
homeostasis. One such source is the synthesis of RA from Roh.
Retinol is clearly available to the epidermis in vivo as significant
quantities of Roh and Roh esters are present in intact epidermis
(Vahlquist and To¨rma¨, 1982). This study suggests that RBP-Roh
permeating into dermal interstitium from the blood supply would not
be significantly metabolized by dermal fibroblasts en route to the
epidermis. This Roh would thus be available to epidermal cells for the
synthesis of RA. In line with this possibility, a number of laboratories
have reported the synthesis of RA from Roh in intact keratinocytes
and in keratinocyte extracts (Siegenthaler et al, 1990; Randolph and
Simon, 1993, 1996; Kurlandsky et al, 1994, 1996; Chatellard-Gruaz
et al, 1998). Thus, suitable concentrations of RA in the epidermis
could be maintained by a balance between limited RA synthesis in situ
and active RA metabolism.
This work was funded in part by Unilever Research U.S.
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